Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Issues Draft Radiofrequency Wireless Guidance For Medical Devices

This article was originally published in The Gray Sheet

Executive Summary

An FDA 1draft guidance released Dec. 29 outlines several design, development and evaluation requirements that manufacturers should incorporate into medical devices with radiofrequency wireless technology

You may also be interested in...



FDA Aims To Stay Ahead Of Wireless Technology Upgrades With Final Guidance

A final guidance released last week attempts to adopt a flexible approach to regulating the rapidly evolving category of devices that employ radiofrequency wireless technology.

FDA Partners With FCC To Spur Wireless Health Technology Development

Manufacturers attending a meeting last week on the convergence of wireless communications and medical devices were encouraged by a new agreement between FDA and the Federal Communications Commission to clarify regulations for the burgeoning product category

FDA Partners With FCC To Spur Wireless Health Technology Development

Manufacturers attending a meeting last week on the convergence of wireless communications and medical devices were encouraged by a new agreement between FDA and the Federal Communications Commission to clarify regulations for the burgeoning product category

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT024331

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel